understanding temporal patterns · understanding temporal patterns in hypertensive drug therapy...

71
Understanding Temporal Patterns in Hypertensive Drug Therapy 1 Margret Bjarnadottir, 2 Sana Malik, 2 Catherine Plaisant, 3 Eberechukwu Onukwugha 1 Smith School of Business, University of Maryland, College Park 2 Department of Computer Science, University of Maryland, College Park 3 School of Pharmacy, University of Maryland, Baltimore May 28, 2015 — HCIL 32 nd Annual Symposium

Upload: others

Post on 18-Jun-2020

6 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Understanding Temporal Patternsin Hypertensive Drug Therapy

1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha

1Smith School of Business, University of Maryland, College Park 2Department of Computer Science, University of Maryland, College Park 3School of Pharmacy, University of Maryland, Baltimore

May 28, 2015 — HCIL 32nd Annual Symposium

Page 2: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

2

๏ Worsened conditions

๏ Adverse outcomes

๏ Increased risk of death

Page 3: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Hospitalization costs due to medication non-adherence are estimated as high as

$13 billion annually.

3

Sullivan et al., “Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate,” Journal of Research in Pharmaceutical Economics, Vol. 2, No. 2. (1990), pp. 19-33.

Page 4: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Medication Possession Ratio (MPR)

4

period nobservatio of lengthsupplied days∑

Page 5: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Medication Possession Ratio (MPR)

4

period nobservatio of lengthsupplied days∑

time

Study  start Study  end

Page 6: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Medication Possession Ratio (MPR)

4

period nobservatio of lengthsupplied days∑

time

Study  start Study  end

=  100%

Page 7: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Medication Possession Ratio (MPR)

4

period nobservatio of lengthsupplied days∑

time

Study  start Study  end

=  83%

Page 8: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Medication Possession Ratio (MPR)

5

period nobservatio of lengthsupplied days∑ =  75%

time

Study  start Study  end

Page 9: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Hypertensive Drug Therapy

Angiotension-Converting Enzyme-Inhibitors

Angiotension II Receptor Blockers

Calcium Channel Blockers

Beta Blockers

Diuretics

6

ACE

ARB

CCB

Beta

Diur

Page 10: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 11: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 12: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 13: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 14: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 15: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 16: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 17: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 18: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 19: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 20: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 21: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 22: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 23: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 24: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 25: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 26: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 27: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 28: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 29: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 30: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 31: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 32: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 33: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

time

Hypertensive Drug Therapy

Page 34: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Can we use visualization tools to more accurately understand adherence

patterns in hypertensive drug therapy?

Page 35: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

11

๏ Can we identify good vs. bad patterns?

๏ Can we understand patient behavior?

Research Questions

Page 36: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Data๏ Commercial prescription claims

๏ 900,000 individuals (16 million claims)

๏ 5 Drug Classes

12

Angiotension-Converting Enzyme-Inhibitors

Angiotension II Receptor Blockers

Calcium Channel Blockers

Beta Blockers

Diuretics

ACE

ARB

CCB

Beta

Diur

Page 37: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging

13

Page 38: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

14

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging Dataset

Page 39: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

14

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging

— Single

} 2 Drugs

} 3 Drugs

} 4 Drugs

— All 5

Page 40: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

15

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging

timeStart  of  record

Page 41: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

15

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging

time2  yearsStart  of  record

Page 42: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

16

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging

time

Page 43: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

16

Data Simplification

๏ Partitioning

๏ Temporal Windowing

๏ Interval Merging

time

Page 44: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

How do allowable gap and overlap assumptions affect adherence

analysis?

Page 45: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Sensitivity Analysis: Allowable Gap

18

0 days 7 days

15 days 30 days

Page 46: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Sensitivity Analysis: Allowable Gap

18

0 days 7 days

15 days 30 days

Page 47: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Sensitivity Analysis: Allowable Gap

18

0 days 7 days

15 days 30 days

Page 48: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Sensitivity Analysis: Allowable Gap

18

0 days 7 days

15 days 30 days

Page 49: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

19

0 days 7 days

15 days 30 days

Sensitivity Analysis: Allowable Overlap

Page 50: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

19

0 days 7 days

15 days 30 days

Sensitivity Analysis: Allowable Overlap

Page 51: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

19

0 days 7 days

15 days 30 days

Sensitivity Analysis: Allowable Overlap

Page 52: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

19

0 days 7 days

15 days 30 days

Sensitivity Analysis: Allowable Overlap

Page 53: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

20

Single DrugsACE

ARB

CCB

Beta

Diur

Page 54: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

20

Single DrugsACE

ARB

CCB

Beta

Diur

Page 55: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

21

2 DrugsACE

Beta

Both

Page 56: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

21

2 DrugsACE

Beta

Both

Page 57: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

22

2 Drugs

false overlap

ACE

Beta

Both

Page 58: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

23

2 DrugsACE

Beta

Both

Page 59: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

24

2 DrugsACE

Beta

Both

Page 60: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

All 5 Drugs

25

2,200 patients

Page 61: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

2,200 patientsAll 5 Drugs

26

Page 62: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

2,200 patientsAll 5 Drugs

26

Page 63: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

2,200 patientsAll 5 Drugs

26

Page 64: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

2,200 patientsAll 5 Drugs

26

Page 65: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

All 5 Drugs

27

2,200 patients

Page 66: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

All 5 Drugs

27

2,200 patients

Page 67: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Starting on Diuretic

28

ACE

ARB

CCB

Beta

Diur150,000 patients

Page 68: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Starting on Diuretic

28

ACE

ARB

CCB

Beta

Diur150,000 patients

Page 69: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Starting on Diuretic

28

ACE

ARB

CCB

Beta

Diur150,000 patients

Page 70: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

Summary

๏ Visualization facilitated rapid understanding of complex patient behavior

๏ Interactions allow systematic analysis of episode modeling

29

Page 71: Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy 1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha 1Smith

30

Understanding Temporal Patternsin Hypertensive Drug Therapy

Sana [email protected]/hcil/eventflow

Thanks to Sophia Wu. Support from the University of Maryland Center for Health-related Informatics and Bioimaging (CHIB).